These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Geranylgeranylacetone, a gastromucoprotective drug, protects against NSAID-induced esophageal, gastroduodenal and small intestinal mucosal injury in healthy subjects: A prospective randomized study involving a comparison with famotidine. Umegaki E, Kuramoto T, Kojima Y, Nouda S, Ishida K, Takeuchi T, Inoue T, Tokioka S, Higuchi K. Intern Med; 2014 Oct; 53(4):283-90. PubMed ID: 24531083 [Abstract] [Full Text] [Related]
30. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease. Rainsford KD, Stetsko PI, Sirko SP, Debski S. J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509 [Abstract] [Full Text] [Related]
34. Role of dietary fiber in formation and prevention of small intestinal ulcers induced by nonsteroidal anti-inflammatory drug. Satoh H. Curr Pharm Des; 2010 May; 16(10):1209-13. PubMed ID: 20166992 [Abstract] [Full Text] [Related]
35. [Actual status and vision of NSAIDs-induced intestinal injuries]. Fujimori S, Sakamoto C. Nihon Rinsho; 2011 Jun; 69(6):1075-82. PubMed ID: 21688631 [Abstract] [Full Text] [Related]
36. Neutrophil extracellular trap formation and its implications in nonsteroidal anti-inflammatory drug-induced small intestinal injury. Moriyama E, Nadatani Y, Higashimori A, Otani K, Ominami M, Fukunaga S, Hosomi S, Tanaka F, Taira K, Fujiwara Y, Watanabe T. J Gastroenterol Hepatol; 2024 Jun; 39(6):1123-1133. PubMed ID: 38576269 [Abstract] [Full Text] [Related]
39. Review article: a practical approach to the clinical management of NSAID enteropathy. Srinivasan A, De Cruz P. Scand J Gastroenterol; 2017 Sep; 52(9):941-947. PubMed ID: 28587496 [Abstract] [Full Text] [Related]